| Rapid development of exhaustion and down-regulation of eomesodermin limit the antitumor activity of adoptively transferred murine natural killer cells. Gill S., Vasey A.E., De Souza A., Baker J., Smith A.T., Kohrt H.E., Florek M., Gibbs K.D. Jr., Tate K., Ritchie D.S. et al.
Blood 119:5758-5768(2012) · Mapped (6) |
| Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells. Shin H.J., Baker J., Leveson-Gower D.B., Smith A.T., Sega E.I., Negrin R.S.
Blood 118:2342-2350(2011) · Mapped (1) |
| Low doses of natural killer T cells provide protection from acute graft-versus-host disease via an IL-4-dependent mechanism. Leveson-Gower D.B., Olson J.A., Sega E.I., Luong R.H., Baker J., Zeiser R., Negrin R.S.
Blood 117:3220-3229(2011) · Mapped (9) |
| NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects. Olson J.A., Leveson-Gower D.B., Gill S., Baker J., Beilhack A., Negrin R.S.
Blood 115:4293-4301(2010) · Mapped (12) |
| Immunoglobulin G Fc receptor FcgammaRIIIa 158 V/F polymorphism correlates with rituximab-induced neutropenia after autologous transplantation in patients with non-Hodgkin's lymphoma. Weng W.K., Negrin R.S., Lavori P., Horning S.J.
J. Clin. Oncol. 28:279-284(2010) · Mapped (6) |
| Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation. Abrahamsson A.E., Geron I., Gotlib J., Dao K.H., Barroga C.F., Newton I.G., Giles F.J., Durocher J., Creusot R.S., Karimi M. et al.
Proc. Natl. Acad. Sci. U.S.A. 106:3925-3929(2009) · Mapped (8) |
| Prevention of acute graft-versus-host disease by blocking T-cell entry to secondary lymphoid organs. Beilhack A., Schulz S., Baker J., Beilhack G.F., Nishimura R., Baker E.M., Landan G., Herman E.I., Butcher E.C., Contag C.H. et al.
Blood 111:2919-2928(2008) · Mapped (3) |
| Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells. Zeiser R., Leveson-Gower D.B., Zambricki E.A., Kambham N., Beilhack A., Loh J., Hou J.Z., Negrin R.S.
Blood 111:453-462(2008) · Mapped (5) |
| Preemptive HMG-CoA reductase inhibition provides graft-versus-host disease protection by Th-2 polarization while sparing graft-versus-leukemia activity. Zeiser R., Youssef S., Baker J., Kambham N., Steinman L., Negrin R.S.
Blood 110:4588-4598(2007) · Mapped (11) |
| Silencing human NKG2D, DAP10, and DAP12 reduces cytotoxicity of activated CD8+ T cells and NK cells. Karimi M., Cao T.M., Baker J.A., Verneris M.R., Soares L., Negrin R.S.
J. Immunol. 175:7819-7828(2005) · UniProtKB (1) · Mapped (2) |
| Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells. Verneris M.R., Karami M., Baker J., Jayaswal A., Negrin R.S.
Blood 103:3065-3072(2004) · Mapped (2) |
| CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Edinger M., Hoffmann P., Ermann J., Drago K., Fathman C.G., Strober S., Negrin R.S.
Nat. Med. 9:1144-1150(2003) · Mapped (7) |
